156 related articles for article (PubMed ID: 37273107)
21. Identification and Functional Validation of Reciprocal microRNA-mRNA Pairings in African American Prostate Cancer Disparities.
Wang BD; Ceniccola K; Yang Q; Andrawis R; Patel V; Ji Y; Rhim J; Olender J; Popratiloff A; Latham P; Lai Y; Patierno SR; Lee NH
Clin Cancer Res; 2015 Nov; 21(21):4970-84. PubMed ID: 26089375
[TBL] [Abstract][Full Text] [Related]
22. miRNA-mRNA correlation-network modules in human prostate cancer and the differences between primary and metastatic tumor subtypes.
Zhang W; Edwards A; Fan W; Flemington EK; Zhang K
PLoS One; 2012; 7(6):e40130. PubMed ID: 22768240
[TBL] [Abstract][Full Text] [Related]
23. miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.
Noonan EJ; Place RF; Basak S; Pookot D; Li LC
Oncotarget; 2010 Sep; 1(5):349-58. PubMed ID: 20948989
[TBL] [Abstract][Full Text] [Related]
24. A Practical Guide to miRNA Target Prediction.
Akhtar MM; Micolucci L; Islam MS; Olivieri F; Procopio AD
Methods Mol Biol; 2019; 1970():1-13. PubMed ID: 30963484
[TBL] [Abstract][Full Text] [Related]
25. Systematic Identification of MicroRNAs That Impact on Proliferation of Prostate Cancer Cells and Display Changed Expression in Tumor Tissue.
Aakula A; Kohonen P; Leivonen SK; Mäkelä R; Hintsanen P; Mpindi JP; Martens-Uzunova E; Aittokallio T; Jenster G; Perälä M; Kallioniemi O; Östling P
Eur Urol; 2016 Jun; 69(6):1120-8. PubMed ID: 26489476
[TBL] [Abstract][Full Text] [Related]
26. Systemic comparison of repression activity for miRNA and siRNA associated with different types of target sequences.
Lee HC; Chen CY; Au LC
Biochem Biophys Res Commun; 2011 Jul; 411(2):393-6. PubMed ID: 21749858
[TBL] [Abstract][Full Text] [Related]
27. The association of let-7c, miR-21, miR-145, miR-182, and miR-221 with clinicopathologic parameters of prostate cancer in patients diagnosed with low-risk disease.
Kurul NO; Ates F; Yilmaz I; Narli G; Yesildal C; Senkul T
Prostate; 2019 Jul; 79(10):1125-1132. PubMed ID: 31045265
[TBL] [Abstract][Full Text] [Related]
28. miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
Wang Y; Lieberman R; Pan J; Zhang Q; Du M; Zhang P; Nevalainen M; Kohli M; Shenoy NK; Meng H; You M; Wang L
Mol Cancer; 2016 Nov; 15(1):70. PubMed ID: 27832783
[TBL] [Abstract][Full Text] [Related]
29. VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription.
Singh PK; Long MD; Battaglia S; Hu Q; Liu S; Sucheston-Campbell LE; Campbell MJ
Epigenetics; 2015; 10(1):40-9. PubMed ID: 25494645
[TBL] [Abstract][Full Text] [Related]
30. Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients.
He HC; Han ZD; Dai QS; Ling XH; Fu X; Lin ZY; Deng YH; Qin GQ; Cai C; Chen JH; Jiang FN; Liu X; Zhong WD
BMC Genomics; 2013 Nov; 14():757. PubMed ID: 24191917
[TBL] [Abstract][Full Text] [Related]
31. A potential regulatory loop between Lin28B:miR‑212 in androgen-independent prostate cancer.
Borrego-Diaz E; Powers BC; Azizov V; Lovell S; Reyes R; Chapman B; Tawfik O; McGregor D; Diaz FJ; Wang X; Veldhuizen PV
Int J Oncol; 2014 Dec; 45(6):2421-9. PubMed ID: 25201220
[TBL] [Abstract][Full Text] [Related]
32. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
Ye Y; Li SL; Wang SY
PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
[TBL] [Abstract][Full Text] [Related]
33. Identification of valid reference genes for mRNA and microRNA normalisation in prostate cancer cell lines.
Zhao H; Ma TF; Lin J; Liu LL; Sun WJ; Guo LX; Wang SQ; Otecko NO; Zhang YP
Sci Rep; 2018 Jan; 8(1):1949. PubMed ID: 29386530
[TBL] [Abstract][Full Text] [Related]
34. MiRNATIP: a SOM-based miRNA-target interactions predictor.
Fiannaca A; Rosa M; Paglia L; Rizzo R; Urso A
BMC Bioinformatics; 2016 Sep; 17(Suppl 11):321. PubMed ID: 28185545
[TBL] [Abstract][Full Text] [Related]
35. MiR-145 affected the circular RNA expression in prostate cancer LNCaP cells.
He JH; Han ZP; Zhou JB; Chen WM; Lv YB; He ML; Li YG
J Cell Biochem; 2018 Nov; 119(11):9168-9177. PubMed ID: 30136305
[TBL] [Abstract][Full Text] [Related]
36. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
[TBL] [Abstract][Full Text] [Related]
37. Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.
Song C; Chen H; Wang T; Zhang W; Ru G; Lang J
Prostate; 2015 Apr; 75(5):500-16. PubMed ID: 25597612
[TBL] [Abstract][Full Text] [Related]
38. Recent updates on the role of microRNAs in prostate cancer.
Hassan O; Ahmad A; Sethi S; Sarkar FH
J Hematol Oncol; 2012 Mar; 5():9. PubMed ID: 22417299
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA detection in prostate tumors by quantitative real-time PCR (qPCR).
Gordanpour A; Nam RK; Sugar L; Bacopulos S; Seth A
J Vis Exp; 2012 May; (63):e3874. PubMed ID: 22643910
[TBL] [Abstract][Full Text] [Related]
40. The roles of binding site arrangement and combinatorial targeting in microRNA repression of gene expression.
Hon LS; Zhang Z
Genome Biol; 2007; 8(8):R166. PubMed ID: 17697356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
